ISRG - Anti-obesity meds can expand the market for weight loss surgery: Bernstein
2024-01-21 12:00:01 ET
More on Intuitive Surgical, J&J, etc.
- Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative
- Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off?
- Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuits And Ambrx Acquisition
- Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more
- Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa
For further details see:
Anti-obesity meds can expand the market for weight loss surgery: Bernstein